Targeted Contrast-enhanced Ultrasound: an Emerging Technology in Abdominal and Pelvic Imaging

Overview

Journal Gastroenterology

Specialty Gastroenterology

Date 2011 Jan 25

PMID 21255573

Citations 27

Authors

Marybeth A Pysz

Jurgen K Willmann

Affiliations

Soon will be listed here.

Citing Articles

Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.

Liberto J, Chen S, Shih I, Wang T, Wang T, Pisanic 2nd T Cancers (Basel). 2022; 14(12).

PMID: 35740550 PMC: 9221480. DOI: 10.3390/cancers14122885.

Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood-Brain Barrier Opening via Lipid-PLGA Nanobubbles.

Yan Y, Chen Y, Liu Z, Cai F, Niu W, Song L Int J Nanomedicine. 2021; 16:7433-7447.

PMID: 34764649 PMC: 8575349. DOI: 10.2147/IJN.S327737.

Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer.

Jugniot N, Bam R, Meuillet E, Unger E, Paulmurugan R Bioeng Transl Med. 2021; 6(1):e10183.

PMID: 33532585 PMC: 7823123. DOI: 10.1002/btm2.10183.

Listening for the therapeutic window: Advances in drug delivery utilizing photoacoustic imaging.

Moore C, Chen F, Wang J, Jokerst J Adv Drug Deliv Rev. 2019; 144:78-89.

PMID: 31295522 PMC: 6745251. DOI: 10.1016/j.addr.2019.07.003.

Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.

Tummers W, Willmann J, Bonsing B, Vahrmeijer A, Gambhir S, Swijnenburg R Pancreas. 2018; 47(6):675-689.

PMID: 29894417 PMC: 6003672. DOI: 10.1097/MPA.0000000000001075.

References

Clarke-Pearson D . Clinical practice. Screening for ovarian cancer. N Engl J Med. 2009; 361(2):170-7. DOI: 10.1056/NEJMcp0901926. View

Wilson S, Burns P . Microbubble-enhanced US in body imaging: what role?. Radiology. 2010; 257(1):24-39. DOI: 10.1148/radiol.10091210. View

Brannigan M, Burns P, Wilson S . Blood flow patterns in focal liver lesions at microbubble-enhanced US. Radiographics. 2004; 24(4):921-35. DOI: 10.1148/rg.244035158. View

Willmann J, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz A . US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008; 246(2):508-18. PMC: 4157631. DOI: 10.1148/radiol.2462070536. View

Kiessling F . Science to practice: the dawn of molecular US imaging for clinical cancer imaging. Radiology. 2010; 256(2):331-3. DOI: 10.1148/radiol.100717. View

Tardy I, Pochon S, Theraulaz M, Emmel P, Passantino L, Tranquart F . Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol. 2010; 45(10):573-8. DOI: 10.1097/RLI.0b013e3181ee8b83. View

Bhayana D, Kim T, Jang H, Burns P, Wilson S . Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. AJR Am J Roentgenol. 2010; 194(4):977-83. DOI: 10.2214/AJR.09.3375. View

Aigner F, Mitterberger M, Rehder P, Pallwein L, Junker D, Horninger W . Status of transrectal ultrasound imaging of the prostate. J Endourol. 2010; 24(5):685-91. DOI: 10.1089/end.2009.0640. View

Seicean A, Badea R, Stan-Iuga R, Gulei I, Pop T, Pascu O . The added value of real-time harmonics contrast-enhanced endoscopic ultrasonography for the characterisation of pancreatic diseases in routine practice. J Gastrointestin Liver Dis. 2010; 19(1):99-104. View

10.

Wilson S, Jang H, Kim T, Iijima H, Kamiyama N, Burns P . Real-time temporal maximum-intensity-projection imaging of hepatic lesions with contrast-enhanced sonography. AJR Am J Roentgenol. 2008; 190(3):691-5. DOI: 10.2214/AJR.07.3116. View

11.

Fleischer A, Lyshchik A, Andreotti R, Hwang M, Jones 3rd H, Fishman D . Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles. AJR Am J Roentgenol. 2010; 194(2):343-8. DOI: 10.2214/AJR.09.3446. View

12.

Correas J, Claudon M, Tranquart F, Helenon A . The kidney: imaging with microbubble contrast agents. Ultrasound Q. 2006; 22(1):53-66. View

13.

Saftoiu A, Vilmann P . Role of endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. J Clin Ultrasound. 2008; 37(1):1-17. DOI: 10.1002/jcu.20534. View

14.

Willmann J, Lutz A, Paulmurugan R, Patel M, Chu P, Rosenberg J . Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008; 248(3):936-44. PMC: 2798094. DOI: 10.1148/radiol.2483072231. View

15.

Helmstaedter L, Riemann J . Pancreatic cancer--EUS and early diagnosis. Langenbecks Arch Surg. 2008; 393(6):923-7. DOI: 10.1007/s00423-007-0275-1. View

16.

Lamuraglia M, Bridal S, Santin M, Izzi G, Rixe O, Angelo Paradiso . Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives. Crit Rev Oncol Hematol. 2009; 73(3):202-12. DOI: 10.1016/j.critrevonc.2009.06.001. View

17.

Wei K, Jayaweera A, Firoozan S, Linka A, Skyba D, Kaul S . Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998; 97(5):473-83. DOI: 10.1161/01.cir.97.5.473. View

18.

Nylund K, Hausken T, Gilja O . Ultrasound and inflammatory bowel disease. Ultrasound Q. 2010; 26(1):3-15. DOI: 10.1097/RUQ.0b013e3181ce0929. View

19.

Meyer D, Schultz J, Lin Y, Henry A, Sanderson J, Jackson J . Reduced antibody response to streptavidin through site-directed mutagenesis. Protein Sci. 2001; 10(3):491-503. PMC: 2374127. DOI: 10.1110/ps.19901. View

20.

Pysz M, Gambhir S, Willmann J . Molecular imaging: current status and emerging strategies. Clin Radiol. 2010; 65(7):500-16. PMC: 3150531. DOI: 10.1016/j.crad.2010.03.011. View